Navigating global patient recruitment with confidence.
How Praxis evaluates the world’s research landscape.
Global clinical trial recruitment brings a host of opportunities and complexities. Those in the clinical trial space face the challenge of answering: How do you recruit across dozens of countries, each with their own diverse populations, digital footprint, and heavily varied infrastructures for research sites?
Here at Praxis, we have more than 20 years of experience answering that question. Within those 20 years, we have supported studies in more than 60 countries, giving us a top-tier understanding of the recruitment space across different regions – both in theory and in practice.
To help our team and clients navigate this space, we created a structured global evaluation system that informs our global decision-making from feasibility to activation.
Country prioritization for recruitment.
Praxis created a proprietary global scoring system that evaluates opportunity to reach our target audience against each country through several criteria. Each area reflects learnings across hundreds of campaigns, combined with insights from our patient engagement department and Intelligence Taskforce. Some of the key criteria we use to guide our strategy is:
-
Epidemiological footprint.
The foundation of our global strategy is understanding where people are and how easily we’ll be able to reach them. We examine disease prevalence along with a variety of possible factors or barriers that may influence recruitment.
This allows us to focus in on countries with a proven patient population – as opposed to just high-level number reporting.
-
Digital reach.
What works on Instagram in the US might not work in Japan. What thrives on CCTV in Brazil may underperform in Germany. Each country has its own media and digital ecosystem, regulatory expectations, and cultural norms. We evaluate a country’s unique digital footprint alongside any regulatory framework to ensure a fit that makes sense.
We blend AI-enabled research with our historical performance data to pinpoint which channels have the best opportunity to reach and resonate with patients in each market.
-
Research site infrastructure.
A quality epidemiological footprint and strong digital presentation doesn’t mean much if a country lacks the operational support needed to translate that into enrollment. We consider historical information with sites in each country as well as client input and patient insights to ensure a country is well-equipped to offer clinical trial support.
This criteria helps us identify not just where patients exist, but where patients can (and ultimately will) realistically enroll.
Why this matters.
You can easily approach strategy as placing ads in various countries and seeing what works. However, having a system in place allows that strategy to be meaningful – making high-confidence decisions across multiple geographies – each with unique rules, behaviors, and constraints.
Our proprietary approach allows sponsors to reduce risk when expanding globally and prioritize centralized recruitment outreach in countries based on actionable intelligence. The result is a recruitment strategy that’s not only global in reach, but locally optimized for each market’s real-world dynamics and patient needs.
Moving forward with confidence.
Global recruitment strategy doesn’t have to feel like navigating a maze of regulations, platforms, and patient behaviors.
Our long-standing patient-centric approach and experience paired with modern intelligence tools gives sponsors a high-confidence path through patient recruitment complexities. Whether you’re activating five countries or 25, our goal is simple:
Make global recruitment feel manageable – and make enrollment achievable.
Let us make your next global trial feel manageable and attainable, Let’s connect!
